BMO Capital analyst Evan Seigerman raised the firm’s price target on Vertex Pharmaceuticals (VRTX) to $545 from $520 and keeps an Outperform ...

EST Vertex Pharmaceuticals (VRTX) up 2% at $448 after FDA Journavx approvalInvest with Confidence: Follow TipRanks' Top Wall Street ...

WASHINGTON (AP) — Federal officials on Thursday approved a new type of pain pill designed to eliminate the risks of addiction ...

It's the first new pharmaceutical approach to treating pain in over 20 years, designed to eliminate risks of addiction and ...

Realty developer M3M India and Max Estates have emerged as the highest bidders for commercial land parcels in Noida, with ...

Vertex, Inc. (NASDAQ: VERX) has announced plans to release its fourth quarter 2024 financial results on the morning of ...

The X Games will experiment judging halfpipe runs this week in Aspen using artificial intelligence, the cutting-edge technology that could someday play a role in the way subjectively judged sports are ...

The list of chains that have closed locations or have plans to shutter stores later in 2025 is growing at a rapid pace. From chain restaurants to clothing stores to auto parts retailers, several ...

Craig Dossey, who presented Karman Line on behalf of developers, is the president of Vertex Consulting Services and former El Paso County planning director. The Colorado Springs City Council ...

Vertex has been running a number of trials because if there’s one thing that we can take away from the failed drug development projects of the past, it’s that there are many kinds of pain.